NCT01461759View on ClinicalTrials.gov

Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Advanced or Recurrent Endometrial Cancer
Interventions
DRUG

Doctaxel

Docetaxel 70mg/m2BSA, q 3 weeks, 8 cycles

DRUG

Cisplatin

Cisplatin 60mg/m2BAS, q 3 weeks, 8 cycles

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Boryung Pharmaceutical Co., Ltd

INDUSTRY

lead

Asan Medical Center

OTHER